Authors: Barzilai, A Melamed, E Shirvan, A

Citation: A. Barzilai et al., Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?, CELL MOL N, 21(3), 2001, pp. 215-235

Authors: Ziv, I Shirvan, A Offen, D Barzilai, A Melamed, E

Citation: I. Ziv et al., Molecular biology of dopamine-induced apoptosis - Possible implications for Parkinson's disease, METH MOL M, 62, 2001, pp. 73-87

Authors: Melamed, E Offen, D Shirvan, A Ziv, I

Citation: E. Melamed et al., Levodopa - an exotoxin or a therapeutic drug?, J NEUROL, 247, 2000, pp. 135-139

Authors: Shirvan, A Shina, R Ziv, I Melamed, E Barzilai, A

Citation: A. Shirvan et al., Induction of neuronal apoptosis by Semaphorin3A-derived peptide, MOL BRAIN R, 83(1-2), 2000, pp. 81-93

Authors: Zilkha-Falb, R Barzilai, A Djaldeti, R Ziv, I Melamed, E Shirvan, A

Citation: R. Zilkha-falb et al., Involvement of T-complex protein-1 delta in dopamine triggered apoptosis in chick embryo sympathetic neurons, J BIOL CHEM, 275(46), 2000, pp. 36380-36387

Authors: Shirvan, A Ziv, I Fleminger, G Shina, R He, ZG Brudo, I Melamed, E Barzilai, A

Citation: A. Shirvan et al., Semaphorins as mediators of neuronal apoptosis, J NEUROCHEM, 73(3), 1999, pp. 961-971